Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase ...

She was joined by her partner Lewis Mann, and the pair raised over £500 for Muscular Dystrophy UK, the leading charity for ...

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone ...

Are you feeling lucky today?” Jennifer Scott, interim superintendent of the Clarke County School District, asked high school ...

Solid Biosciences ( ($SLDB) ) has released its Q2 earnings. Here is a breakdown of the information Solid Biosciences presented to its investors.

Catalyst Pharmaceuticals stock shines with FIRDAPSE & AGAMREE growth. Learn why the biopharma name is cheap enough to start ...

Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to ...

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...

Vor Bio appoints Dallan Murray as chief commercial officer, leveraging his extensive experience to drive commercialization ...

Mixed options sentiment in Pfizer (PFE), with shares down 2c near $24.55. Options volume relatively light with 39k contracts traded and calls ...

BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...